Vimian Group AB (publ) (STO: VIMIAN) Stock Analysis & Fundamentals | ScreenerHero

Create free account

VIMIANVimian Group AB (publ)

STO · SE · Healthcare · Diagnostics & Research · vimian.com

30.30SEK+0.50%Mkt Cap: 1.53B $P/E: 38.853d ago

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through four segments: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. The company offers proprietary diagnostics, pres…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/E

Pricier

P/B

Pricier

1M Perf

Avg

Thermo Fisher Scientific Inc.

$194.52BUSDP/E 28.7

Danaher Corporation

$140.09BUSDP/E 38.3

Lonza Group Ltd

$45.77BUSDP/E 44.2

IDEXX Laboratories, Inc.

$44.00BUSDP/E 41.0

Waters Corporation

$37.24BUSDP/E 48.3

Agilent Technologies, Inc.

$36.91BUSDP/E 26.2

IQVIA Holdings Inc

$34.55BUSDP/E 25.7

$28.55BUSDP/E 34.4

Mettler-Toledo International, Inc.

$26.44BUSDP/E 30.8

Quest Diagnostics Incorporated

$23.88BUSDP/E 23.8

Laboratory Corporation of America Holdings

$23.53BUSDP/E 25.4

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.92BUSDP/E 35.1

Eurofins Scientific SE

$13.05BUSDP/E 27.2

Revvity Inc. Common Stock

$12.69BUSDP/E 54.7

Charles River Laboratories International, Inc.

bioMerieux S.A.

$8.90BUSDP/E 20.8

Twist Bioscience Corp.

BillionToOne Inc. Class A Common Stock

$5.54BUSDP/E 222.9

Sotera Health Company

$5.11BUSDP/E 43.7

$4.55BUSDP/E 52.9

DiaSorin S.p.A.

$3.76BUSDP/E 26.4

Adaptive Biotechnologies Corp.

GRAIL Inc. Common Stock

GeneDx Holdings Corp. Class A Common Stock

NeoGenomics, Inc.

Diagnostyka S.A.

$1.55BUSDP/E 23.4

Personalis, Inc.

OPKO Health, Inc.

Clinica Baviera, S.A.

$1.03BUSDP/E 21.7

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$305.89MUSDP/E 3.1

Spectral Medical Inc.

Insight Molecular Diagnostics Inc. Common Stock

FONAR Corporation

$120.20MUSDP/E 19.1

Eurofins-Cerep SA

$94.30MUSDP/E 18.1

Pangaea Oncology, S.A.

Abingdon Health Plc

$10.08MUSDP/E 63.3

XWELL Inc. Common Stock

Proteome Sciences plc

Oxford BioDynamics Plc

ENDRA Life Sciences Inc.

bioAffinity Technologies Inc. Common Stock

Avricore Health Inc.

iSpecimen Inc. Common Stock

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Med BioGene Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap1.53B $

Enterprise Value1.49B $

Revenue (TTM)41.47M $

Gross Profit28.01M $

Net Income (TTM)2.99M $

Revenue/Share0.0787 USD

Last Price30.30 SEK

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees1.3K

CountrySE

SectorHealthcare

IndustryDiagnostics & Research

ISINSE0015961982

Valuation

P/E (Trailing)38.85

P/E (Forward)21.95

PEG—

EV/EBITDA148.65

EV/Revenue35.96

P/S35.64

P/B21.39

EPS (TTM)0.78

EPS (Forward)1.33

52W Range

24.1832% of range43.58

52W High43.58 SEK

52W Low24.18 SEK

Profitability

Gross Margin68.89%

Oper. Margin18.19%

EBITDA Margin24.19%

Profit Margin7.36%

ROE4.48%

ROA2.82%

Growth

Revenue Growth7.90%

Earnings Growth125.60%

Cash Flow & Leverage

Operating CF10.11M $

CapEx (TTM)1.44M $

FCF Margin13.01%

FCF Yield0.35%

Net Debt18.88M $

Net Debt/EBITDA1.88

Balance Sheet

Debt/Equity0.34

Current Ratio1.71

Quick Ratio0.95

Book Value/Sh1.365 SEK

Cash/Share0.0960 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 SEK

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating2.2 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)35.32 SEK

Upside (mean)+16.6%

Target Range26.48 SEK – 41.07 SEK

SEK26.48+16.6% to meanSEK41.07

# Analysts6

Ownership

Shares Out.528.32M

Float185.43M

Insiders6.46%

Institutions86.70%

Technical

SMA 5029.49 (+2.8%)

SMA 20028.94 (+4.7%)

Beta1.17

S&P 52W Chg20.05%

Avg Vol (30d)478.00K

Avg Vol (10d)686.25K

Technical Indicators

RSI (14)56.6

MACD0.2081

MACD Signal0.1878

MACD Hist.+0.0202

BB Upper31.69 SEK

BB Middle29.59 SEK

BB Lower27.48 SEK

BB Width14.23%

ATR (14)1.146 SEK

Vol Ratio (20d)0.51x